Non-small Cell Lung Cancer Therapeutics Market Size, Share & Trends Report

Non-small Cell Lung Cancer Therapeutics Market Size, Share & Trends Analysis Report By Drug (Alimta, Iressa, Avastin, Tarceva, Zykadia, Tagrisso, Xalkori, Cyramza), By Region, & Segment Forecasts, 2018 - 2025

  • Report ID: GVR-1-68038-703-2
  • Number of Pages: 100
  • Format: Electronic (PDF)
  • Historical Range: 2014 - 2016
  • Industry: Healthcare

Table of Content

Chapter 1 Research Methodology
                   1.1 Information Procurement
                   1.2 Data Analysis
Chapter 2 Executive Summary
                   2.1 Market Snapshot
Chapter 3 Non-small Cell Lung Cancer Therapeutics Market Variables, Trends & Scope
                   3.1 Market Segmentation and Scope
                       3.1.1 Market driver analysis
                            3.1.1.1 Strong pipeline
                            3.1.1.2 Rising prevalence of NSCLC
                       3.1.2 Market restraint analysis
                            3.1.2.1 Pricing pressure
                   3.2 Penetration & Growth Prospects Mapping
                   3.3 Non-small Cell Lung Cancer Therapeutics Market - PESTLE Analysis
                   3.4 Industry Analysis - Porter’s
                   3.5 Non-small Cell Lung Cancer Therapeutics Competitive Scenario, 2015
                       3.5.1 Competitive landscape: Market position analysis (based on product portfolio, regional presence and strategic initiatives)
Chapter 4 Non-small Cell Lung Cancer Therapeutics: Drug Estimates & Trend Analysis
                   4.1 Global Non-small Cell Lung Cancer Therapeutics Market: Drug Movement Analysis & Market Share, 2016 & 2025
                   4.2 Alimta
                       4.2.1 Alimta market estimates and forecasts, 2014 - 2025 (USD Million)
                   4.3 Iressa
                       4.3.1 Iressa market estimates and forecasts, 2014 - 2025 (USD Million)
                   4.4 Avastin
                       4.4.1 Iressa market estimates and forecasts, 2014 - 2025 (USD Million)
                   4.5 Tarceva
                       4.5.1 Tarceva market estimates and forecasts, 2014 - 2025 (USD Million)
                   4.6 Zykadia
                       4.6.1 Zykadia market estimates and forecasts, 2014 - 2025 (USD Million)
                   4.7 Tagrisso
                       4.7.1 Tagrisso market estimates and forecasts, 2014 - 2025 (USD Million)
                   4.8 Xalkori
                       4.8.1 Xalkori market estimates and forecasts, 2014 - 2025 (USD Million)
                   4.9 Cyramza
                       4.9.1 Cyramza market estimates and forecasts, 2014 - 2025 (USD Million)
                   4.10 Opdivo
                       4.10.1 Opdivo market estimates and forecasts, 2014 - 2025 (USD Million)
                   4.11 Alecensa
                       4.11.1 Alecensa market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 5 Non-small Cell Lung Cancer Therapeutics: Regional Estimates & Trend Analysis
                   5.1 Regional Movement Analysis & Market Share, 2016 & 2025
                   5.2 North America
                       5.2.1 North America non-small cell lung cancer therapeutics market, by drug, 2014 - 2025 (USD Million) 
                       5.2.2 North America non-small cell lung cancer therapeutics market, by country, 2014 - 2025 (USD Million) 
                       5.2.3 The U.S.
                            5.2.3.1 U.S. non-small cell lung cancer therapeutics market, by drug, 2014 - 2025 (USD Million)
                       5.2.4 Canada
                            5.2.4.1 Canada non-small cell lung cancer therapeutics market, by drug, 2014 - 2025 (USD Million)
                   5.3 Europe
                       5.3.1 Europe non-small cell lung cancer therapeutics market, by drug, 2014 - 2025 (USD Million)
                       5.3.2 Europe non-small cell lung cancer therapeutics market, by country, 2014 - 2025 (USD Million)
                       5.3.3 Germany
                            5.3.3.1 Germany non-small cell lung cancer therapeutics market, by drug, 2014 - 2025 (USD Million)
                       5.3.4 UK
                            5.3.4.1 UK non-small cell lung cancer therapeutics market, by drug, 2014 - 2025 (USD Million)
                   5.4 Asia Pacific
                       5.4.1 Asia Pacific non-small cell lung cancer therapeutics market, by drug, 2014 - 2025 (USD Million)
                       5.4.2 Asia Pacific non-small cell lung cancer therapeutics market, by country, 2014 - 2025 (USD Million)
                       5.4.3 Japan
                            5.4.3.1 Japan non-small cell lung cancer therapeutics market, by drug, 2014 - 2025 (USD Million)
                       5.4.5 China 
                            5.4.5.1 China non-small cell lung cancer therapeutics market, by drug, 2014 - 2025 (USD Million)
                   5.5 Latin America
                       5.5.1 Latin America non-small cell lung cancer therapeutics market, by drug, 2014 - 2025 (USD Million)
                       5.5.2 Latin America non-small cell lung cancer therapeutics market, by country, 2014 - 2025 (USD Million)
                       5.5.3 Brazil
                            5.5.3.1 Brazil non-small cell lung cancer therapeutics market, by drug, 2014 - 2025 (USD Million)
                       5.5.4 Mexico 
                            5.5.4.1 Mexiconon-small cell lung cancer therapeutics market, by drug, 2014 - 2025 (USD Million)
                   5.6 MEA
                       5.6.1 MEA non-small cell lung cancer therapeutics market, by drug, 2014 - 2025 (USD Million)
                       5.6.2 MEA non-small cell lung cancer therapeutics market, by country, 2014 - 2025 (USD Million)
                       5.6.3 South Africa
                            5.6.3.1 South Africa non-small cell lung cancer therapeutics market, by drug, 2014 - 2025 (USD Million)
Chapter 6 Competitive Landscape
                   6.1 GlaxoSmithKline (GSK) Plc
                       6.1.1 Company overview
                       6.1.2 Financial performance
                       6.1.3 Product benchmarking
                       6.1.4 Strategic initiatives
                   6.2 Novartis
                       6.2.1 Company overview
                       6.2.2 Financial performance
                       6.2.3 Product benchmarking
                       6.2.4 Strategic initiatives
                   6.3 AstraZeneca 
                       6.3.1 Company overview
                       6.3.2 Financial performance
                       6.3.3 Product benchmarking
                       6.3.4 Strategic initiatives
                   6.4 F. Hoffmann-La Roche Ltd
                       6.4.1 Company overview
                       6.4.2 Financial performance
                       6.4.3 Product benchmarking
                       6.4.4 Strategic initiatives
                   6.5 Bristol Myers Squibb Company
                       6.5.1 Company overview
                       6.5.2 Financial performance
                       6.5.3 Product benchmarking
                       6.5.4 Strategic initiatives
                   6.6 Pfizer, Inc.
                       6.6.1 Company overview
                       6.6.2 Financial performance
                       6.6.3 Product benchmarking
                       6.6.4 Strategic Initiatives
                   6.7 Eli Lilly and Company 
                       6.7.1 Company overview
                       6.7.2 Financial performance
                       6.7.3 Product benchmarking
                       6.7.4 Strategic initiatives
                   6.8 Sanofi
                       6.8.1 Company overview
                       6.8.2 Financial performance
                       6.8.3 Product benchmarking
                       6.8.4 Strategic initiatives


List of Tables

TABLE 1 Non-small cell cancer therapeutics market - global market current and forecast by regions (2015 - 2024) in (USD Million)
TABLE 2 North America non-small cell cancer therapeutics market estimates and forecasts, by country, 2014 - 2025 (USD Million)
TABLE 3 North America non-small cell cancer therapeutics market estimates and forecasts, by drug, 2014 - 2025 (USD Million)
TABLE 4 U.S. non-small cell cancer therapeutics market estimates and forecasts, by drug, 2014 - 2025 (USD Million)
TABLE 5 Canada non-small cell cancer therapeutics market estimates and forecasts, by drug, 2014 - 2025 (USD Million)
TABLE 6 Europe non-small cell cancer therapeutics market estimates and forecasts, by country, 2014 - 2025 (USD Million)
TABLE 7 Europe non-small cell cancer therapeutics market estimates and forecasts, by drug, 2014 - 2025 (USD Million)
TABLE 8 UK non-small cell cancer therapeutics market estimates and forecasts, by drug, 2014 - 2025 (USD Million)
TABLE 9 Germany non-small cell cancer therapeutics market estimates and forecasts, by drug, 2014 - 2025 (USD Million)
TABLE 10 Asia Pacific non-small cell cancer therapeutics market estimates and forecasts, by country, 2014 - 2025 (USD Million)
TABLE 11 Asia Pacific non-small cell cancer therapeutics market estimates and forecasts, by drug, 2014 - 2025 (USD Million)
TABLE 12 Japan non-small cell cancer therapeutics market estimates and forecasts, by drug, 2014 - 2025 (USD Million)
TABLE 13 China non-small cell cancer therapeutics market estimates and forecasts, by drug, 2014 - 2025 (USD Million)
TABLE 14 Latin America non-small cell cancer therapeutics market estimates and forecasts, by country, 2014 - 2025 (USD Million)
TABLE 15 Latin America non-small cell cancer therapeutics market estimates and forecasts, by drug, 2014 - 2025 (USD Million)
TABLE 16 Brazil non-small cell cancer therapeutics market estimates and forecasts, by drug, 2014 - 2025 (USD Million)
TABLE 17 Mexico non-small cell cancer therapeutics market estimates and forecasts, by drug, 2014 - 2025 (USD Million)
TABLE 18 MEA non-small cell cancer therapeutics market estimates and forecasts, by country, 2014 - 2025 (USD Million)
TABLE 19 MEA non-small cell cancer therapeutics market estimates and forecasts, by drug, 2014 - 2025 (USD Million)
TABLE 20 South Africa non-small cell cancer therapeutics market estimates and forecasts, by drug, 2014 - 2025 (USD Million)


List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & Forecasting
FIG. 6 QFD modeling for market share assessment
FIG. 7 Market summary
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market restraint relevance analysis (Current & future impact)
FIG. 12 Penetration & growth prospect mapping
FIG. 13 Non-small cell lung cancer therapeutics market - PESTLE analysis
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Non-small cell lung cancer therapeutics market outlook key takeaways
FIG. 16 Non-small cell lung cancer therapeutics market: drug movement analysis
FIG. 17 Global non-small cell lung cancer therapeutics market, by drug, 2014 - 2025 (USD Million)
FIG. 18 Global Alimta market, 2014 - 2025 (USD Million)
FIG. 19 Global Iressa market, 2014 - 2025 (USD Million)
FIG. 20 Global Avastin market, 2014 - 2025 (USD Million)
FIG. 21 Global Tarceva market, 2014 - 2025 (USD Million)
FIG. 22 Global Zykadia market, 2014 - 2025 (USD Million)
FIG. 23 Global Tagrisso market, 2014 - 2025 (USD Million)
FIG. 24 Global Xalkori market, 2014 - 2025 (USD Million)
FIG. 25 Global Cyramza market, 2014 - 2025 (USD Million)
FIG. 26 Global Opdivo market, 2014 - 2025 (USD Million)
FIG. 27 Global Alecensa market, 2014 - 2025 (USD Million)
FIG. 28 Regional market: Key takeaways
FIG. 29 Non-small cell lung cancer therapeutics market regional outlook, 2015 & 2025
FIG. 30 North America non-small cell lung cancer therapeutics market, 2014 - 2025 (USD Million)
FIG. 31 U.S. non-small cell lung cancer therapeutics market, 2014 - 2025 (USD Million)
FIG. 32 Canada non-small cell lung cancer therapeutics market, 2014 - 2025 (USD Million)
FIG. 33 Europe non-small cell lung cancer therapeutics market, 2014 - 2025 (USD Million)
FIG. 34 Germany non-small cell lung cancer therapeutics market, 2014 - 2025 (USD Million)
FIG. 35 UK non-small cell lung cancer therapeutics market, 2014 - 2025 (USD Million)
FIG. 36 Asia Pacific non-small cell lung cancer therapeutics market, 2014 - 2025 (USD Million)
FIG. 37 Japan non-small cell lung cancer therapeutics market, 2014 - 2025 (USD Million)
FIG. 38 China non-small cell lung cancer therapeutics market, 2014 - 2025 (USD Million)
FIG. 39 Latin America non-small cell lung cancer therapeutics market, 2014 - 2025 (USD Million)
FIG. 40 Brazil non-small cell lung cancer therapeutics market, 2014 - 2025 (USD Million)
FIG. 41 Mexico non-small cell lung cancer therapeutics market, 2014 - 2025 (USD Million)
FIG. 42 Middle East Africa non-small cell lung cancer therapeutics market, 2014 - 2025 (USD Million)
FIG. 43 South Africa non-small cell lung cancer therapeutics market, 2014 - 2025 (USD Million)
FIG. 44 Strategy frameworks

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon gvr sidebar D&B icon gvr sidebar

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.